Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplemental Table 2 from Multi-center phase I trial of Ivosidenib as Maintenance Treatment following Allogeneic Hematopoietic Cell Transplantation for IDH1-Mutated Acute Myeloid Leukemia
  1. Home
  2. Publications
  3. Supplemental Table 2 from Multi-center phase I trial of Ivosidenib as Maintenance Treatment following Allogeneic Hematopoietic Cell Transplantation for IDH1-Mutated Acute Myeloid Leukemia

Supplemental Table 2 from Multi-center phase I trial of Ivosidenib as Maintenance Treatment following Allogeneic Hematopoietic Cell Transplantation for IDH1-Mutated Acute Myeloid Leukemia

Authors:
  • AFAmir T. Fathi
    Amir T. Fathi
  • HKHaesook T. Kim
    Haesook T. Kim
  • RSRobert J. Soiffer
    Robert J. Soiffer
  • MLMark J. Levis
    Mark J. Levis
  • SLShuli Li
    Shuli Li
  • AKAnnette S. Kim
    Annette S. Kim
  • ZDZachariah DeFilipp
    Zachariah DeFilipp
  • AEAreej El-Jawahri
    Areej El-Jawahri
  • SMSteve L. McAfee
    Steve L. McAfee
  • ABAndrew M. Brunner
    Andrew M. Brunner
  • PAPhilip C. Amrein
    Philip C. Amrein
  • AMAlice S. Mims
    Alice S. Mims

Open Access
Publisher website
Google Scholar
  • 16 September 2024
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1078-0432.27030739
Abstract
Marrow IDH1 VAF prior to Transplant and Maintenance
Keywords
  • CLINICAL TRIAL RESULTS
  • PHASE I CLINICAL TRIALS
  • DRUG TARGETS
  • ONCOPROTEIN & TUMOR SUPPRESSOR DRUG TARGETS
  • HEMATOLOGICAL CANCERS
  • LEUKEMIAS
  • IMMUNOTHERAPY
  • STEM CELL TRANSPLANTATION
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.